The Vatican has launched a meticulous three-month restoration of Michelangelo's iconic 'Last Judgment' fresco in the Sistine Chapel, aiming to revive the masterpiece's original chromatic brilliance obscured by decades of grime.
A suspected human smuggler with a prior conviction was shot by federal agents near the Arizona-Mexico border after allegedly firing at a CBP helicopter and agents during a foot pursuit, according to law enforcement officials.
Google has agreed to a $135 million settlement to resolve a class-action lawsuit alleging unauthorized data collection by its Android operating system, pending court approval. The deal also mandates clearer user controls and disclosures.
Chinese biotech firm Arctic Vision moves to create an integrated ophthalmology powerhouse by acquiring MDCO Technology's device business, combining drug and device expertise to address unmet needs in eye care.
The S&P 500 is home to market leaders, but not all its constituents are created equal. We examine one company navigating challenges and two others positioned for potential growth, providing context on their valuations and market positions.
While stocks priced between $10 and $50 can appear to offer an attractive balance of accessibility and maturity, their low price tags can sometimes mask underlying vulnerabilities. We examine three such companies where caution may be prudent.
The vital Rafah border crossing between Gaza and Egypt partially reopened Monday, allowing severely limited civilian movement for the first time since its capture by Israeli forces in 2024. The cautious resumption follows intense international pressure but falls far short of addressing Gaza's overwhelming humanitarian crisis.
The vital Rafah border crossing between Gaza and Egypt has partially reopened after a prolonged closure, a key provision of the US-mediated ceasefire. The move allows for limited humanitarian movement under stringent security oversight by Israel and Egypt.
CONMED's latest earnings reveal a strategic pivot towards higher-growth surgical platforms, moving away from slower gastroenterology lines. While sales climbed, profitability softened, setting the stage for a crucial transition year as the market weighs the company's reset valuation against its ambitious 2026 roadmap.
The Rafah border crossing between Gaza and Egypt reopened for pedestrian traffic Monday, ending a near two-year shutdown. The vital gateway, crucial for aid and movement, resumes under a complex new security framework involving Israeli oversight and international monitors.
Israel announces a limited, security-heavy reopening of Gaza's Rafah crossing with Egypt, allowing some medical evacuations while concerns mount over aid access and the safety of returnees.
A San Antonio family's morning commute turned to terror when a driver, angered by a brief honk, opened fire on their vehicle, critically wounding a child in the backseat.
Peter Mandelson, a pivotal figure in the Blair-era Labour Party, has resigned his membership following fresh allegations concerning his ties to the late financier Jeffrey Epstein, marking another blow to the party's establishment.
Stryker Corporation's latest earnings report, driven by its MedSurg, Neurotechnology divisions and the Mako surgical robot, has reignited investor debate. With shares near $370 and a bullish fair value estimate of $427, analysts are weighing robust growth against a premium valuation.
Buoyed by strategic brand exits and tariff mitigation, Church & Dwight enters 2026 with robust cash flow and a sharpened focus on its 'power brands' like Arm & Hammer and TheraBreath, despite a challenging consumer landscape.
Analyst Matthew O'Brien reaffirms an Overweight rating and $420 price target for Stryker, highlighting the potential of its new Mako RPS handheld orthopedic robot to capture cost-sensitive markets and compete with rivals like Zimmer Biomet.
A routine online marketplace transaction ended in tragedy when a 19-year-old man allegedly stabbed a pregnant mother dozens of times during a vehicle sale, prosecutors revealed. The victim's family describes the attack as 'pure evil' as they mourn a life built on kindness.
German industrial giant Thyssenkrupp is exploring the sale of a significant minority stake in its Rothe Erde bearings division, a move analysts say could signal a broader portfolio reshuffle and highlight persistent valuation gaps within the conglomerate.
The medical technology giant reported double-digit organic sales growth and robust profitability for 2025, driven by record installations of its Mako surgical robots. While projecting continued strength for 2026, management acknowledged incremental tariff pressures but expressed confidence in the company's ability to sustain margin expansion.
Despite a lowered price target following an analyst transition, TD Cowen maintains a bullish stance on Alphatec Holdings, citing undervalued growth drivers including a new regenerative bone graft partnership and a robust long-term revenue outlook.
